Khalid Ashai is a Cardiology physician. OpenAlex indexes 6 publications with 597 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9301 Largo Dr W Ste 201
Largo, MD 207744884
Telephone
301-615-2522Provider last certified this registry record 16 Mar 2026.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals US, Inc.Program year20256 payments
- Merck Sharp & Dohme LLCProgram year20257 payments
- PFIZER INC.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73%Statin15.2%Atorvastatin Calcium47%Rosuvastatin Calcium41%Pravastatin Sodium9%Simvastatin3%Part D<11 patientsBeta blocker11.2%Metoprolol Succinate45%Carvedilol31%Atenolol8%Metoprolol Tartrate7%Atenolol-Chlorthalidone6%Nebivolol Hcl2%Part D<11 patients+ 21 more classes in this area
Blood & clotting
16.2%Factor Xa inhibitor8.8%Xarelto50%Eliquis50%Part D≥76 patientsP2Y12 inhibitor5.6%Clopidogrel89%Brilinta12%Part D≥102 patients+ 3 more classes in this area
Metabolism & gastrointestinal
10.1%SGLT2 inhibitor5.2%Jardiance52%Farxiga42%Dapagliflozin6%Part D<11 patientsGLP-1 receptor agonist1.3%Ozempic85%Trulicity15%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty
Arteriosclerosis Thrombosis and Vascular Biology
2001 - The experimental animal models for assessing treatment of restenosis
Cardiovascular Radiation Medicine
1999
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”